申请人:XW LABORATORIES INC.
公开号:US10640476B2
公开(公告)日:2020-05-05
The present invention relates compounds of Formula (A), as well as their preparation and uses, and further relates pharmaceutical compositions comprising these compounds and their uses as modulators of dysfunctional glutamate transmission. The present invention also relates to uses of the compounds or pharmaceutical compositions in treating or preventing certain neurological and psychiatric disorders and diseases as well as cancer in humans.
本发明涉及式(A)化合物及其制备方法和用途,还涉及包含这些化合物的药物组合物及其作为谷氨酸传递障碍调节剂的用途。本发明还涉及这些化合物或药物组合物在治疗或预防某些神经和精神疾病以及人类癌症方面的用途。